Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy With Carboplatin and Paclitaxel for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01386385
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:08.103958+00:00
Published At
2021-07-12T00:00:00+00:00
Record Updated At
2026-04-20
Results Posted At
2021-07-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Adenocarcinoma", "Lung Adenocarcinoma, Mixed Subtype", "Lung Large Cell Carcinoma", "Lung Squamous Cell Carcinoma", "Minimally Invasive Lung Adenocarcinoma", "Stage III Lung Non-Small Cell Cancer AJCC v7", "Stage IIIA Lung Non-Small Cell Cancer AJCC v7", "Stage IIIB Lung Non-Small Cell Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-20"
protocolSection.identificationModule.nctId
"NCT01386385"
protocolSection.identificationModule.officialTitle
"A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy With Carboplatin and Paclitaxel for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-07-12"

Study condition terms

  • Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Lung Adenocarcinoma, Mixed Subtype (protocolSection.conditionsModule.conditions)
  • Lung Large Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Lung Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Minimally Invasive Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.